About Sollers

Sollers is a graduate school located in New Jersey, specializing in clinical research, drug safety and pharmacovigilance training.

Our graduate certificate and masters programs cover a wide range of subjects tailored to this fast growing industry, and our graduates go on to highly successful careers in the pharmaceuticals industry and healthcare industries.

  • HOURS
  • Monday - Thursday | 10 AM - 7 PM
  • Friday | 12 PM - Midnight
  • Saturday | 12 PM - Midnight
  • Sunday | Closed
  • OPEN 24/7 - sollers.edu
    • PHONE
    • (848) 299-5900
    • Location
    • 100 Menlo Park, Suite 550
      Edison New Jersey 08837 -2488

Location

Call Us Now: 848 299-5900

Sollers Blog

Ethics of Human Research Subjects, Synopsis

Posted by Doctor Dan on Oct 4, 2017 12:57:08 PM

As early as January 18, this year, the US Department of Health and Human Services (HHS), via the Office of Human Research and Protection (OHRP), released the final regulations (the Final Rule), bringing about notable changes to the Federal Policy for the Protection of Human Subjects (The Common Rule), according to a Hallrender.com report.

Read More

Topics: Drug Safety

Natural Language Processing Market to touch $22.3 billion by 2025

Posted by Doctor Erick on Sep 29, 2017 2:32:00 PM

Natural language processing (NLP) is a technology spawned from the need for machines to understand and communicate with humans in human language, not formal computer languages, says a company statement.

Read More

Topics: Data Science

Global Pharmaceutical Industry to Grow at a CAGR of 4-7% during the next five years

Posted by Doctor Dan on Sep 28, 2017 1:36:20 PM

Total spending on medicines is projected to touch $1.5 trillion by 2021, up 33% from 2016 levels even as annual growth moderates from the record pace set in 2014 and 2015, writes Patricia Van Arnum on connect.dcat.org. The recent analysis by QuintilesIMS forecasts that the global pharmaceutical industry will grow at a compound annual growth rate of 4-7% during the next five years, down from the nearly 9% growth level seen in 2014 and 2015.

Read More

Topics: Drug Safety

QSP Enhances Value to Drug Development

Posted by Phil on Sep 25, 2017 12:56:27 PM

The pharmaceutical industry is huge and has a direct impact on millions of patients across the world and the industry deals with a large amount of crucial data that needs to be organized, processed, and worked on effectively for efficient patient care and valuable drug development.

Read More

Topics: Drug Safety

Patient Data Access is a Right Guaranteed by HIPAA Regulations

Posted by Doctor Dan on Sep 22, 2017 12:05:12 PM

Individuals have an inherent right to access their own health information. Patient data access can be a critical tool for proper care, but both providers and patients often face confusion about how HIPAA regulations impact the exchange and release of protected health information (PHI).

Read More

Topics: Clinical Research

Reasons Why Healthcare Should Have Data Science

Posted by Phil on Sep 21, 2017 12:05:16 PM

Big data has made great inroads into a slew of industries. Healthcare, being one of the big and complex industries in the US, it is ideal for big data initiatives.

Read More

Topics: Data Science

Role of Pharmacovigilance for Drug Safety

Posted by Doctor Erick on Sep 20, 2017 12:56:40 PM

Pharmacovigilance is a vital factor to have a cohesive drug regulation system in place, in terms of tracking and assessing adverse drug reactions (ADRs). Pharmacovigilance encompasses a crucial role in the clinical research and it is showing humongous growth. Currently, the worldwide network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world, according to a media statement by sbwire.com.

Read More

Topics: Drug Safety

Environment Monitoring Using Risk Based Approach - 2

Posted by Doctor Dan on Sep 19, 2017 12:58:22 PM

In the Clinical Research arena, the Environmental Monitoring (EM) Program - comprising of viable and non-viable monitoring elements – is designed to routinely monitor particulates as well as micro-organisms in key spears of pharmaceutical manufacturing facility, especially in the aseptic processing areas. While the viable or micro-biological monitoring is replete with routine monitoring of the manufacturing environment for the trace of micro-organisms, the non-viable particulate monitoring, calculates the airborne particle count and further offers inputs on the routine maintenance of the clean room air classification.

Read More

Topics: Clinical Research

Amazon might foray into Clinical Trials Segment

Posted by Doctor Dan on Sep 18, 2017 12:43:12 PM

The global e-commerce Major Amazon has made many awestruck with its foray into the hitherto untapped area of healthcare. Although, the company has a perfect platform for selling any product under the sun, including pharmaceutical items, but then why should it get into healthcare segment is the question that begs an answer, according to medium.com report.

Read More

Topics: Clinical Research

Mobile Data For Clinical Trial-2

Posted by Phil on Sep 15, 2017 4:22:53 PM

A new research report, published in the Journal of Medical Internet Research reveals that the mobile device (Mobile Technology) can effectively support a slew of things within the clinical research such as project management, data management, and telemonitoring, according to a mhealthintelligence.com report.

Read More

Topics: Clinical Research